Boston Scientific (BSX)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-10 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BOSTON SCIENTIFIC CORP (BSX) CIK: 0000885725 --- Reporting Owner --- Name: Monson Jonathan CIK: 0001779170 Role: Officer (EVP and CFO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-10 | Code: I (Discretionary (intra-plan)) Shares: +9,908 | Price: $50.46 Total Value: $499,957.68 Shares Owned After: 9,908 | Ownership: I (Indirect) | Nature: By 401(k) Footnotes: [F1] Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock. --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock. --- Signature --- /s/ /s/ Susan Thompson, Attorney-in-Fact (2026-08-11)